[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615343":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":30,"centralContacts":31,"locations":30,"responsibleParty":37,"collaborators":30,"id":41,"slug":30,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":30,"eligibilityCriteria":46,"healthyVolunteers":47,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":30,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":30,"overallStatus":60,"whyStopped":30,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":30},{"fullName":5,"class":6},"Minia University","OTHER",[8,13],{"label":9,"type":6,"description":10,"interventionNames":11},"Control group","this group who undergoing iv contrast will receive hydration only",[12],"Other: Hydration",{"label":14,"type":6,"description":15,"interventionNames":16},"Amlodipine group","this group will receive hydration and amlodipine",[17,12],"Drug: Calcium channel blocker",[19,26],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Calcium channel blocker","amlodipine group will receive low dose oral amlodipine ( 5 mg ) before iv contrast and every 12 hour for 48 hour",[14],[25],"amlodipine ( 5mg)",{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"Hydration","before the procedure patients will recieve iv bolus of 250 ml saline followed by continous infusion of 100 ml\u002Fh of normal saline",[14,9],null,[32],{"name":33,"role":34,"phone":35,"phoneExt":30,"email":36},"Andrew Shehata, Master","CONTACT","0201067820073","andrewlengouini.95@gmail.com",{"type":38,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"PRINCIPAL_INVESTIGATOR","Andrew Samy Shafeek Shehata","Andrew Samy Shafeek","100615343",false,"NCT07291375","Role of Amlodipine in Reduction of CIN","The Effect of Low Dose Oral Amlodipine in Renal Protection From Contrast Induced Nephropathy in Diabetic Patients in Intensive Care Unit","Inclusion Criteria:\n\n* adult patients of both sexes (18:70) diabetic patients with serum creatinine below 1.2 hemodynamically stable patients ASA physical status 2,3\n\nExclusion Criteria:\n\n* patient refusal patients of chronic kidney diseases NPO patients serum creatinine above 1.2 Hypertensive patients",true,"ALL","18 Years","70 Years",{"count":52,"type":53},40,"ESTIMATED","INTERVENTIONAL",[56],"EARLY_PHASE1","The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit",[59],"Contrast-induced Nephropathy","NOT_YET_RECRUITING","2025-12-05",{"date":63,"type":64},"2025-12-18","ACTUAL",{"date":66,"type":53},"2025-12-20",{"date":68,"type":53},"2026-07-01",{"name":5,"class":6}]